Peter Schiff, chief economist and global strategist at Euro Pacific Asset Management and founder of Schiff Gold, shares his outlook on gold
Is gold’s price pullback a buying opportunity, or the end of its run? Omar Ayales of Gold Charts R Us weighs in,
Jordan Roy-Byrne, CMT, MFTA, editor and publisher of the Daily Gold, discusses how long the gold and silver correction could last, and
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division —
Here’s a quick recap of the crypto landscape for Friday (November 7) as of 9:00 p.m. UTC. Get the latest insights on
Rich Checkan, president and COO of Asset Strategies International, shares his thoughts on the recent pullback in gold and silver prices, emphasizing
Surface Metals Inc. (CSE: SUR,OTC:SURMF) (OTCQB: SURMF) (the ‘Company’, or ‘Surface Metals’) has granted 250,000 options priced at $0.255 to a consultant,
